American medical device companies have written to the US government asking that it suspend or partly or fully withdraw India's benefits under the Generalized System of Preferences (GSP) "in view of its failure to provide equitable and reasonable access to its market for medical devices". AdvaMed stated that it recently learned that NPPA has already calculated ceiling prices for a number of other medical devices and was just waiting for the prime minister's order. "Indonesia, Bangladesh and Pakistan are reportedly considering India-type price controls. "The US has technical barriers to trade under USFDA, while these are near non-existent in India for US device companies. Indian manufacturers are barred from selling to the US government-funded health programmes and defence as India is not listed under the US Trade Agreement Act.

Source: Times of India October 25, 2017 01:46 UTC